WITHDRAWN: PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor coordination-associated side effects in neuropathic pain model.

Li C, Su C, Wang Z, Han R, Wang Y, Wang H, Tian J, Gao Y

Open source

DOI
10.1016/j.taap.2020.115208
Published
2020 Aug 21
Container
Toxicology and applied pharmacology
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.taap.2020.115208,
  title = {WITHDRAWN: PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor coordination-associated side effects in neuropathic pain model.},
  author = {Li C and Su C and Wang Z and Han R and Wang Y and Wang H and Tian J and Gao Y},
  year = {2020},
  journal = {Toxicology and applied pharmacology},
  doi = {10.1016/j.taap.2020.115208},
  url = {https://doi.org/10.1016/j.taap.2020.115208}
}

RIS

TY  - JOUR
TI  - WITHDRAWN: PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor coordination-associated side effects in neuropathic pain model.
AU  - Li C
AU  - Su C
AU  - Wang Z
AU  - Han R
AU  - Wang Y
AU  - Wang H
AU  - Tian J
AU  - Gao Y
PY  - 2020
JO  - Toxicology and applied pharmacology
DO  - 10.1016/j.taap.2020.115208
UR  - https://doi.org/10.1016/j.taap.2020.115208
ER  - 

APA

C, L., C, S., Z, W., R, H., Y, W., H, W., J, T., & Y, G. (2020). WITHDRAWN: PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor coordination-associated side effects in neuropathic pain model.. Toxicology and applied pharmacology. https://doi.org/10.1016/j.taap.2020.115208

Source records